Opinion: STAT readers respond on the ethics of gender-aff...

What’s Happening

Alright so Authors of HHS report criticize recent STAT op-ed on gender-affirming care for minors for using “scare tactics.

” First Opinion First Opinion As a scientist and NFL widow, I am furious about a recent NFL Players Association-funded CTE study By Eleanor M. Perfetto First Opinion First Opinion I treated children for rotavirus in Denmark. (yes, really)

The Danish vaccine schedule is no model for the U.

The Details

By Michael Thwing First Opinion First Opinion Former FDA commissioner: HHS leadership is focused on policy-based evidence, not evidence-based policy By Robert M. Califf First Opinion First Opinion TrumpRx has a fundamental flaw By Sean D.

Hansen First Opinion First Opinion We helped create Medicare Advantage. Here’s how to fix it By Donna Shalala and Tommy G.

Why This Matters

Thompson STAT Plus: Vertex’s CRISPR treatment for sickle cell disease hits unexpected roadblock By Jason Mast STAT Plus: A rival goes after Ocular Therapeutix on eve of pivotal readout on eye treatment By Adam Feuerstein STAT Plus: Trump administration officials blocked FDA effort to fast-track review of psychedelic treatment By Lizzy Lawrence , Elaine Chen , and Damian Garde STAT Plus: FDA Commissioner Marty Makary tries to soothe staff concerns over voucher program By Lizzy Lawrence STAT Plus: Nektar Therapeutics is trying to stage a comeback.

This is the kind of health news that affects everyday decisions.

The Bottom Line

This story is still developing, and we’ll keep you updated as more info drops.

Sound off in the comments.